Human and non-human primate intestinal and LN samples and flow cytometry
Human intestinal tissue from the ileum and mesenteric lymph node (mLN) were obtained from cadaver organ donors in collaboration with the New York Organ Donor Network or through the Cooperative Human Tissue Network. All donors were adults aged 20-60 years. Consent for use of these tissues from human cadavers for research purposes was obtained from the donors' families. Two Chinese rhesus macaques were housed at BIOQUAL (Rockville, MD) according to the standards of the American Association for Accreditation of Laboratory Animal Care. Single cell suspensions from LN were obtained by cutting tissues into small pieces and subjected to mechanical disruption through a syringe. Remaining tissues were then mechanically dissociated, strained through a wire mesh tissue sieve and lymphocytes were subsequently separated by centrifugation through Ficoll (LSM; Invitrogen). Single cell suspensions from intestinal tissues were obtained by cutting tissues into small pieces and incubating for 1-2 h at 37 °C with shaking in stripping buffer (1 mM EDTA, 1 mM DTT and 5% FCS) to remove the epithelial layer. Supernatants were then discarded and the lamina propria fraction was obtained by incubating the remaining tissue for 1-2 h at 37 °C with shaking in collagenase solution. Remaining tissues were then mechanically dissociated, strained through a wire mesh tissue sieve and lymphocytes were subsequently separated by centrifugation through Ficoll.
For flow cytometry, single cell suspensions were stimulated overnight in recombinant human IL-2, IL-7 and IL-23 (10 ng/mL; eBioscience) followed by incubation for 4-6 h with 10 µg/mL Brefeldin A (Sigma-Aldrich). Cells were stained with antibodies to the following markers: anti-CD3 PE-Cy7 (clone UCHT1, eBiosciene, human only), anti-CD3 APC (clone 10D2, Miltenyi Biotec, non-human primate only), anti-CD56 eFluor780 (clone CMSSB, eBioscience), anti-CD20 eFluor780 (clone 2H7, eBioscience), anti-CD45 PerCP-Cy5.5 (clone 2D1, eBioscience, human only), CD45 PerCP-Cy5.5 (clone TU116, BD Biosciences, non-human primate only) and anti-CD127 PE-Cy5 (clone R34.34, Beckman Coulter). For intracellular staining, cells were fixed and permeabilized utilizing a commercially available kit (eBioscience) and stained with antiRORγt PE (clone AFKJS-9, eBioscience) or anti-IL-22 eFluor660 (clone 22URTI, eBioscience, human only). For non-human primates, IL22-104 (Pfizer) was conjugated to Alexa Fluor 647 or Alexa Fluor 488 according to manufacturer's instructions (Molecular Probes). Dead cells were excluded from analysis using a violet viability stain (Invitrogen). Flow cytometry data collection was performed on a LSR II (BD Biosciences). Files were analyzed using FlowJo software (Tree Star Inc.).
Human sera samples
Sera from patients with Crohn's disease and healthy controls were obtained from children undergoing upper endoscopy and colonoscopy for evaluation of suspected IBD as part of Institutional Review Board (IRB)-approved studies at the Children's Hospital of Philadelphia Research Institute. Patients with normal biopsy results were used as controls. Crohn's disease was diagnosed on the basis of the biopsy results, endoscopic appearance and radiological evaluation. Patient information is summarized in Table S2 . Plasma was obtained from HCV-infected individuals and seronegative healthy adults recruited from the Philadelphia VA Medical Center and the Hospital of University of Pennsylvania with informed consent approved by the respective IRBs.
Murine tissue isolation and flow cytometry
Spleens were harvested and single-cell suspensions were prepared at necropsy. For LPL isolation, intestines were isolated, attached fat removed and tissues cut open longitudinally. Luminal contents were removed by shaking in cold PBS and tissue was cut into 1-2 cm pieces and washed in RPMI containing 5% FCS. Epithelial cells and intra-epithelial lymphocytes were removed by shaking tissue in stripping buffer (1 mM EDTA, 1 mM DTT and 5% FCS) for 30 minutes at 37°C. The lamina propria layer was isolated by shaking the remaining tissue in 0.5 mg/mL collagenase D (Roche) and 20 µg/mL DNase I (Sigma-Aldrich) for 30 minutes at 37°C.
For flow cytometric analysis, cells were stained with antibodies to the following markers, anti-NK1.1 PerCP-Cy5.5 (clone PK136, eBioscience), anti-CD3 PE-Cy7 (clone 145-2C11, eBioscience), CD90.2 Alexa 700 (clone 30-H12, Biolegend), anti-CD127 eFluor450 (clone A7R34, eBioscience), anti-CD45 eFluor650NC (clone 30-F11, eBioscience), anti-CD90.1 PerCP-Cy5.5 (clone HIS51, eBioscience), anti-CD4 PE-Texas Red (clone GK1.5, Abcam), anti-CD8 APC-eFluor780 (clone 53-6.7, eBioscience), anti-CD19 Alexa700 (clone 6D5, Biolegend). For intracellular staining, cells were fixed and permeabilized utilizing a commercially available kit (eBioscience) and stained with antiRORγt PE (clone AFKJS-9, eBioscience) or Ki-67 Alexa Fluor488 (clone B56, BD Biosciences). For cytokine production, SI LPL cells were stimulated directly ex vivo by incubation for 4 h with 50 ng/mL PMA, 750 ng/mL ionomycin, 10 µg/mL Brefeldin A (all obtained from Sigma-Aldrich) and 10 ng/mL rIL-23 (eBioscience) or splenocytes were incubated for 5 h with 10 µg/mL Brefeldin A following antigen restimulation. Cells were fixed and permeabilized as indicated above and stained with IL22-02 (Pfizer) conjugated to Alexa Fluor 647 according to manufacturer's instructions (Molecular Probes), anti-IL-6 (clone MP5-20F3, eBioscience) and anti-TNFα APC (clone MP6-XT22, eBioscience). Dead cells were excluded from analysis using a violet viability stain (Invitrogen). Flow cytometry data collection was performed on a LSR II (BD Biosciences). Files were analyzed using FlowJo software (Tree Star Inc.).
Measurement of CFU and liver LPS
Organs were sterilely removed at necropsy and mechanically homogenized in sterile PBS. CFU were determined via serial dilutions on LB agar (Invitrogen). Colonies were counted after 2 days of culture at 37°C. LPS was measured in homogenates using an Endpoint Chromogenic Limulus Amebocyte Lysate assay (Lonza).
FITC-dextran and fecal albumin intestinal permeability assays
Translocation of intestinal FITC-dextran was measured as previously described (21) . Briefly, mice were orally gavaged with 150 µL of FITC-dextran (4 kDa; Sigma) at 80 mg/mL in sterile PBS. Mice were euthanized 4-8 hours later and sera was collected and measured at 485 nm excitation / 535 emission. Fecal pellets were homogenized in sterile PBS and murine serum albumin was measured by ELISA following the protocol of a commercially available kit (Bethyl Laboratories, Inc.).
Quantitative real-time PCR RNA was isolated from epithelial cells stripped from the ileum using RNeasy mini kits (QIAGEN). cDNA was generated using Superscript reverse transcription (Invitrogen). Real-time PCR (RT-PCR) was performed on cDNA using SYBR green chemistry (Applied Biosystems) and commercially available primer sets (QIAGEN). Reactions were run on a real-time PCR system (ABI7500; Applied Biosystems). Samples were normalized to β-actin and displayed as a fold change from naïve isotypetreated controls unless otherwise stated.
Histological sections
Tissue samples from the liver or ileum were fixed with 4% paraformaldehyde, embedded in paraffin, and 5 µm sections were used for staining with H&E.
CD90-disparate Rag1
-/-chimeras CD90 disparate chimeras were generated as previously described (13) . In brief, cells from mLN and spleen of CD90.1 C57BL/6 mice were obtained and approximately 60-80 x 10 6 sort purified B (CD19 + ) and T cells (CD3 + , CD5 + ) were transferred i.v. to CD90.2 Rag1 -/-mice. Reconstitution was permitted for 8-10 weeks post-transfer and subsequently confirmed by examination of peripheral blood lymphocytes.
Injection of purified Alcaligenes and monoassociation of germ-free mice
Pure cultures of Alcaligenes were obtained and approximately 1x10 3 -1x10 4 CFU were injected i.v. into mice every other day for 6 consecutive days. Germ-free mice were maintained in gnotobiotic conditions and orally gavaged with 2 doses of 10 9 -10 12 purified cultures of Alcaligenes.
Mouse serology
Serum was shipped on dry ice to Charles River Laboratories for comprehensive serology (assessment plus) employing multiplexed fluorometric immunoassays.
Metabolite analysis, 16S PCR, pyrosequencing and fluorescent in situ hybridization (FISH) for Alcaligenes.
Individual colonies from experimental mice were sub-cultured at Charles River Laboratories on Tryptose Blood Agar (aerobic), Tergitol-7 Agar (aerobic), Columbia Blood Agar (aerobic), PI agar (aerobic) and Schaedler Agar (Anaerobic). Cultures exhibiting positive growth were subjected to comprehensive analysis of metabolites on a Vitek 2 compact, which employs biochemical tests to analyze bacterial growth and metabolic changes in the presence of numerous substrates. This system has previously been validated to have a high success rate at identifying gram negative bacteria (22) . 16S ribosomal-directed PCR specific for Alcaligenes spp. was performed as previously described (29) . DNA from luminal contents from the intestine of mice or LB cultures from homogenized spleen and liver of anti-CD90.2 mAb treated mice was obtained using the PSP Spin Stool DNA Plus Kit (Stratec molecular). DNA samples were amplified using the V1-V2 region primers targeting bacterial 16S genes and sequenced using 454/Roche Titanium technology. Sequence analysis was carried out using the QIIME pipeline (30) .
FISH and confocal microscopy were performed as previously described (4) on mice housed at the University of Pennsylvania. Probes were used specific for Alcaligenes and Bordetella (ALBO) and Alcaligenes, Burkholderia and Comamonas (BPA). Alcaligenes spp. were identified as cells positive for both probes. Wheat germ agglutinin (WGA) was used to identify epithelial cells.
Bacterial antigen preparation, antigen restimulation and Alcaligenes-specific ELISA Livers from anti-CD90 mAb-treated Rag1 -/-mice were homogenized in sterile PBS and cultured overnight in LB broth to obtain a culture of Alcaligenes bacteria or cultures were obtained from Alcaligenes (ATTC#31444) or E.coli (ATTC#35328). Cultures were briefly centrifuged at 1,000 rpm to remove large aggregates, and the resulting supernatant was washed with sterile PBS twice by centrifuging for 1 minute at 8,000 rpm. On the last wash, bacteria were resuspended in 2 mL ice-cold PBS and sonicated on ice. Samples were then centrifuged at 20,000 x g for 10 minutes and supernatants recovered for a crude antigen preparation. For T cell antigen restimulation, splenocytes were cultured with 50 µg/mL crude Alcaligenes antigen for 48-72 hours followed by the addition of 10 µg/mL Brefeldin A for 5 hours at 37°C. For measurement of serum antibodies by ELISA, 5 µg/mL Alcaligenes antigen was coated on 96 well plates and sera were incubated in doubling dilutions. Antigen specific IgG was detected using an anti-mouse IgG-HRP antibody (BD Biosciences) or anti-human IgG-HRP antibody (BD Biosciences). Plates were developed with TMB peroxidase substrate (KPL) and optical densities measured on a plate spectrophotometer. Where noted some ELISA were performed using bacterial membrane antigens prepared by overnight culturing of Alcaligenes or E.coli in Luria Broth, followed by a 1 hour incubation in 0.1% SDS.
Statistical analysis
Results represent the mean ± SEM. For mouse studies, statistical significance was determined by the Student's t test. The growth of Alcaligenes in culture with the presense or absence of S100A8/A9 was compared by one-way ANOVA. Alcaligenesspecific IgG levels in control and disease patients were compared by the Mann-Whitney test. The association between Alcaligenes-specific IgG levels and clinical parameters was compared by non-parametric Spearman's rank correlation coefficient (r s ). (*, p < 0.05; **, p < 0.01; ***, p < 0.001). -/-mice were analyzed for the presence of Alcaligenes by a 16S ribosomalspecific PCR. All data are representative of 2 or more independent experiments with a minimum of 3-4 mice per group. ND, none detected. All data are representative of 3 independent experiments with a minimum of 3 mice per group. Data shown are the mean ± SEM. * p < 0.05 , *** p < 0.001. Fig. S11 . Levels of Alcaligenes-specific plasma IgG do not correlate with age or serum ALT in HCV infected patients. Relative serum IgG (OD values per g/mL total serum IgG) specific to Alcaligenes crude antigens in chronic HCV infected individuals (n=27) were correlated with (A) patient age or (B) serum levels of alanine transaminase (sALT). The association between Alcaligenes-specific IgG levels and clinical parameters were compared by non-parametric Spearman's rank correlation coefficient (r s ). 
